Repository logo
 

Automated telecommunication interventions to promote adherence to cardio-metabolic medications: meta-analysis of effectiveness and meta-regression of behaviour change techniques.

Published version
Peer-reviewed

Change log

Authors

Abstract

Automated telecommunication interventions, including short message service and interactive voice response, are increasingly being used to promote adherence to medications prescribed for cardio-metabolic conditions. This systematic review aimed to comprehensively assess the effectiveness of such interventions to support medication adherence, and to identify the behaviour change techniques (BCTs) and other intervention characteristics that are positively associated with greater intervention effectiveness. Meta-analysis of 17 randomised controlled trials showed a small but statistically significant effect on medication adherence, OR = 1.89, 95% CI [1.51, 2.36], I2 = 89%, N = 25,101. Multivariable meta-regression analysis including eight BCTs explained 88% of the observed variance in effect size (ES). The BCTs 'tailored' and 'information about health consequences' were positively and significantly associated with ES. Future studies could explore whether the inclusion of these and/or additional techniques (e.g., 'implementation intentions') would increase the effect of automated telecommunication interventions, using rigorous designs and objective outcome measures.

Description

Keywords

Medication adherence, behaviour change techniques, cardio-metabolic conditions, interactive voice response, meta-regression, text messaging, Antihypertensive Agents, Behavior Therapy, Diabetes Mellitus, Humans, Hypoglycemic Agents, Medication Adherence, Myocardial Infarction, Randomized Controlled Trials as Topic, Reminder Systems, Stroke, Telemedicine, Text Messaging, Treatment Outcome

Journal Title

Health Psychol Rev

Conference Name

Journal ISSN

1743-7199
1743-7202

Volume Title

12

Publisher

Informa UK Limited
Sponsorship
National Institute for Health Research (NIHR) (via Cambridgeshire and Peterborough Clinical Commissioning Group (CCG)) (15859 / PB-PG-0215-36032)